Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-20-065556

Chief Executive Officer gave 1,126 shares (gift)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Anzalone Christopher Richard Chief Executive Officer 2020-12-28 Gift −1,126 2,544,621 D
Loading xslF345X03/doc4.xml…